Bitget Hosts Crypto Experience Month 2025 Targeting Gen-Zs Across Europe, Asia and Middle East
Crypto Experience Month 2025 is built around a simple tagline: Look What Crypto Can Do. While headlines often frame digital assets around market movements, this campaign flips the narrative, focusing instead on how blockchain is being applied in payments, gaming, DeFi, identity, and creative expression. Across pop-up activations set to roll out globally this August, Bitget is inviting young people to try crypto for themselves, not on charts, but in checkout lines, in metaverse arcades, and through everyday interactions.
From university campuses to creative hubs, attendees will explore zones where they can mint NFTs, experiment with stablecoin lending, trade tokenized stocks in real-time simulations, and test drive PayFi's QR-based retail transactions. They'll receive digital badges, load up a Bitget Wallet Mastercard, and even stake assets in DeFi setups guided by in-person educators. The format is designed to merge experience with understanding, where every station is part demo, part discovery.
The shift from education to interaction marks a new chapter for the campaign. Launched in 2023 with Crypto Experience Day, the campaign expanded to an entire month in 2024, reaching over 15,000 participants across 12 countries. This year's edition pushes further, prioritizing physical presence and hands-on engagement to help bridge the growing gap between Web2 curiosity and Web3 confidence.
Vugar Usi Zade, Bitget's Chief Operating Officer and the executive sponsor of Blockchain4Youth, believes that relevance comes from application. 'You can't build belief in the future of crypto through theory alone. You need to let people feel it, use it, question it,' he said. 'Crypto Experience Month is about making the technology real and giving young people a reason to care about where it's going.'
Bitget Wallet will serve as the official campaign partner, integrating its latest features, including PayFi, and on-chain tools into the experience zones. Jamie Elkaleh, Chief Marketing Officer at Bitget Wallet, added, 'The onboarding is just the start. It's also about showing how crypto can empower everyday actions, from payments to creativity. We're excited to bring that vision to life on the ground.'
Followers of the campaign can look forward to a recap video capturing highlights from each activation in early September. Until then, Bitget's message is clear: crypto isn't just coming to the real world. It's already here, and this August, it's handing over the controls to the next generation.
About Bitget
Established in 2018, Bitget is the world's leading cryptocurrency exchange and Web3 company. Serving over 120 million users in 150+ countries and regions, the Bitget exchange is committed to helping users trade smarter with its pioneering copy trading feature and other trading solutions, while offering real-time access to Bitcoin price, Ethereum price, and other cryptocurrency prices. Bitget Wallet is a leading non-custodial crypto wallet supporting 130+ blockchains and millions of tokens. It offers multi-chain trading, staking, payments, and direct access to 20,000+ DApps, with advanced swaps and market insights built into a single platform.
Bitget is driving crypto adoption through strategic partnerships, such as its role as the Official Crypto Partner of the World's Top Football League, LALIGA, in EASTERN, SEA and LATAM markets, as well as a global partner of Turkish National athletes Buse Tosun Çavuşoğlu (Wrestling world champion), Samet Gümüş (Boxing gold medalist) and İlkin Aydın (Volleyball national team), to inspire the global community to embrace the future of cryptocurrency.
Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. In the world of motorsports, Bitget is the exclusive cryptocurrency exchange partner of MotoGP™, one of the world's most thrilling championships.
Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Global Sulforaphane Broccoli Sprout Powder Market Set to Reach USD 1.2 Billion by 2033, Driven by Rising Demand for Preventive Healthcare and Organic Wellness Products
The global Sulforaphane Broccoli Sprout Powder market is anticipated to reach a valuation of approximately USD 1.2 billion by 2033, registering robust growth fueled by increasing awareness around health, wellness, and disease prevention. The market's expansion is primarily driven by the growing preference for organic and plant-based nutraceuticals, rising consumer demand for natural preventive healthcare solutions, and the widespread adoption of functional foods and dietary supplements. London, UK – August 2025 — According to the newly published market intelligence report from Strategic Revenue Insights, the Sulforaphane Broccoli Sprout Powder Market is projected to grow at a CAGR of 7.5% between 2025 and 2033, reaching a global valuation of approximately USD 1.2 billion by the end of the forecast period. The report provides detailed insights across product types, applications, regional trends, and the evolving competitive landscape. Sulforaphane, a powerful phytochemical found in broccoli sprouts, has emerged as a sought-after compound in the nutraceutical, pharmaceutical, and functional food sectors. Backed by a growing body of research supporting its anti-cancer, detoxification, and anti-inflammatory properties, sulforaphane broccoli sprout powder has witnessed a surge in consumer demand, particularly in the dietary supplement market. Health-Conscious Consumers Fuel Global Market Expansion The increasing shift toward organic, plant-based, and preventive health solutions is one of the most significant trends influencing consumer preferences today. The demand for organic sulforaphane broccoli sprout powder has gained notable traction, capturing a growing share of the market as consumers gravitate toward chemical-free, sustainably sourced products. 'Consumers are not just seeking treatment anymore—they're looking for ways to prevent illness, boost immunity, and extend vitality,' said Rohit, Partner at Strategic Revenue Insights. 'Sulforaphane offers a science-backed, natural solution, and the market is responding accordingly.' Key Market Segments and Regional Insights The report segments the global market by product type, application, distribution channel, and end-user, with notable insights including: Product Type: Organic sulforaphane broccoli sprout powder is growing at a CAGR of 8.0%, outperforming conventional counterparts due to rising demand for clean-label products and environmental sustainability. Application: Dietary supplements lead in market share, followed by functional foods and pharmaceuticals. The pharmaceutical segment, growing at 8.5% CAGR, is poised for significant expansion as research around sulforaphane's therapeutic applications gains momentum. Distribution Channels: Online retail is the fastest-growing channel (CAGR 8.2%), driven by consumer preference for convenience, broader product variety, and direct-to-consumer wellness brands. End-User: Individual consumers account for the largest share, supported by the self-care trend and increasing incorporation of sulforaphane into daily wellness routines. Regionally, North America dominates with a market size of USD 300 million and a strong CAGR of 6.8%, thanks to its robust dietary supplement ecosystem and regulatory support for natural health products. However, Asia Pacific is expected to grow the fastest at a CAGR of 8.2%, fueled by rising disposable incomes, rapid urbanization, and increasing awareness of functional nutrition. Top Country-Level Trends United States: Largest market globally, valued at USD 150 million, with growth supported by strong health awareness and mature retail infrastructure. China: Rapidly expanding market (CAGR 9.0%), driven by a rising middle class and proactive wellness trends. Germany and Japan: Both countries exhibit strong growth in Europe and Asia respectively, reflecting consumer preference for high-quality, organic supplements. Import-Export Trade Dynamics Trade activity reflects strong global interest in sulforaphane-based products. The U.S. and China lead both in import and export volumes, underscoring their dual role as producers and consumers. Countries such as Germany, Japan, and Brazil are also gaining relevance as exporters and regional demand centers. Competitive Landscape: Innovation and Strategic Growth The competitive landscape is moderately consolidated, with leading companies focusing on product innovation, organic certifications, R&D investments, and e-commerce expansion. Key players include: Brassica Protection Products LLC (15% market share) Jarrow Formulas, Inc. Source Naturals NutraValley NOW Foods Thorne Research Life Extension, among others These players are actively developing high-bioavailability formulations, expanding into functional food and pharma-grade segments, and leveraging digital marketing to increase consumer reach. Technology and Sustainability Trends Advancements in extraction and formulation technologies have improved the shelf life, purity, and concentration levels of sulforaphane in powder form. Simultaneously, sustainability initiatives are gaining traction, with companies increasingly emphasizing organic farming, green packaging, and transparent labeling to meet evolving consumer expectations. Strategic Outlook: 2025 to 2033 The report highlights several future opportunities and strategic foresight elements: Accelerated integration of sulforaphane into pharmaceuticals and cosmeceuticals. Private label expansion and D2C brand growth in online retail channels. Greater penetration in emerging markets through localized manufacturing and tailored marketing. Investment opportunities in product R&D, clinical trials, and AI-enabled personalized nutrition. Despite challenges such as high pricing of organic inputs and regulatory compliance hurdles, the market remains on a strong upward trajectory. About Strategic Revenue Insights Strategic Revenue Insights is a leading market research and consulting firm delivering actionable intelligence across 100+ industries. Our insights help clients anticipate disruption, uncover opportunities, and craft winning strategies. We specialize in natural health, nutraceuticals, food tech, and functional ingredients — bringing precision, depth, and foresight to every engagement. To access the full Sulforaphane Broccoli Sprout Powder Market Report, visit: Sulforaphane Market Report – Strategic Revenue Insights Media Contact Company Name: Strategic Revenue Insights Inc. Contact Person: Shreyas Email: Send Email Phone: +44 7877403352 Address: Suite10 Capital House 61 Amhurst Road, E8 1LL City: London State: London Country: United Kingdom Website:
Globe and Mail
4 hours ago
- Globe and Mail
FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y
Fresenius Medical Care AG & Co. FMS reported second-quarter 2025 adjusted earnings per share (EPS) of 52 cents, which surpassed the Zacks Consensus Estimate by 4%. The bottom line improved 36.8% year over year. FMS' Revenue Details Revenues of $5.44 billion (EUR 4,792 million) beat the Zacks Consensus Estimate by 1.6%. The top line increased 1% year over year and 5% at constant currency (cc). Also, revenues were up 7% organically. Per management, during the second quarter, divestitures realized as part of the portfolio optimization plan hurt revenue development by EUR 6 million. The full-year top-line numbers are anticipated to reflect 100 basis points of negative impact due to the portfolio optimization plan in 2024. Shares of FMS gained nearly 2.2% in yesterday's after-market trading. The stock has risen 7.9% year to date against the industry 's decline of 8.8%. The S&P 500 Index has increased 7.4% in the same period. Segmental Details Fresenius Medical implemented a new operating model in 2024 and started reporting under two new segments, Care Delivery and Care Enablement. Care Delivery The segment's revenues were down 3% on a year-over-year basis but up 1% at cc. However, revenues gained 4% on an organic basis. Revenues in the U.S. markets declined 2% reportedly but gained 3% on an organic basis. The top line also improved 3% year over year at cc. Per management, unfavorable exchange rates along with increased mortality due to the severe flu season in the United States in the first months of the year hurt sales in the country. However, this was partially offset by an accelerated number of patient new starts, reimbursement rate increases and a favorable payor mix. Per management, during the first quarter of 2025, U.S. same-market treatment growth remained flat year over year. International sales declined 8% reportedly as well as at cc but gained 5% on an organic basis. The decline was due to divestments realized as part of the portfolio optimization plan, which was partially offset by organic growth. The organic growth was supported by accelerated same-market treatment growth of 1.7%. Care Enablement The segment's revenues decreased 1% year over year reportedly but gained 3% at cc as well as organically. Volume growth and continued positive pricing momentum were offset by unfavorable exchange rate effects. Margin Analysis In the quarter under review, Fresenius Medical's gross profit improved 4.2% year over year. The gross margin expanded 90 basis points (bps) to 25.4%. Selling, general & administrative expenses increased 2.7% on a reported basis. Research and development expenses decreased 17.4% year over year. Adjusted operating income improved 9.2% from the prior-year quarter's level. The adjusted operating margin in the second quarter expanded 80 bps to 9.9%. 2025 Guidance For 2025, Fresenius Medical continues to expect revenue growth to be positive, with a low-single-digit percent rate compared to the prior year. The company also expects operating income to grow by a high-teens to high-twenties percent rate compared to the prior year. Our Take FMS exited the second quarter on a strong note, with its earnings and revenues surpassing their respective consensus estimate. Overall pricing momentum also supported growth in the Care Enablement segment. However, the effects of elevated mortality will likely continue to have a negative impact on sales. Per management, during the first quarter, the FME25 transformation program continued its positive momentum, delivering EUR 58 million additional sustainable savings while related one-time costs, treated as special items, amounted to EUR 53 million. The company confirmed its full-year target of around EUR 180 million in additional annual savings, totaling EUR 1050 million by 2027-end. FMS' continued divestment of its non-core and dilutive assets appears promising, as it will help focus on its core and growing categories, while also boosting its cash resources. FMS' Zacks Rank & Other Stocks to Consider Fresenius Medical currently sports a Zacks Rank #1 (Strong Buy). Some other top-ranked stocks in the broader medical space that have announced quarterly results are Medpace Holdings, Inc. MEDP, West Pharmaceutical Services, Inc. WST and Boston Scientific Corporation BSX. Medpace Holdings, sporting a Zacks Rank of 1 at present, reported second-quarter 2025 EPS of $3.10, which beat the Zacks Consensus Estimate by 3.3%. You can see the complete list of today's Zacks #1 Rank stocks here. Revenues of $603.3 million outpaced the consensus mark by 11.5%. Medpace Holdings has a long-term estimated growth rate of 11.4%. MEDP's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 13.9%. West Pharmaceutical reported second-quarter 2025 adjusted EPS of $1.84, which beat the Zacks Consensus Estimate by 21.9%. Revenues of $766.5 million surpassed the Zacks Consensus Estimate by 5.4%. It currently flaunts a Zacks Rank #1. West Pharmaceutical has a long-term estimated growth rate of 8.5%. WST's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%. Boston Scientific reported second-quarter 2025 adjusted EPS of 75 cents, which beat the Zacks Consensus Estimate by 4.2%. Revenues of $5.06 billion surpassed the Zacks Consensus Estimate by 3.5%. It currently carries a Zacks Rank #2 (Buy). Boston Scientific has a long-term estimated growth rate of 14%. BSX's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 8.1%. Zacks' Research Chief Picks Stock Most Likely to "At Least Double" Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren't winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%. See Our Top Stock to Double (Plus 4 Runners Up) >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX): Free Stock Analysis Report Fresenius Medical Care AG & Co. KGaA (FMS): Free Stock Analysis Report West Pharmaceutical Services, Inc. (WST): Free Stock Analysis Report Medpace Holdings, Inc. (MEDP): Free Stock Analysis Report
Toronto Star
7 hours ago
- Toronto Star
₿itopia by Bitget Turns Heartbeats into Art at UNTOLD Romania
CLUJ‑NAPOCA, Romania, Aug. 06, 2025 (GLOBE NEWSWIRE) — Bitget, the world's leading cryptocurrency exchange and Web3 company, unveils ₿itopia: #FeelThe₿eat, Interactive 360° Digital installation at UNTOLD X Festival in Romania from August 7–11. This experience combines the scale of UNTOLD's famously elaborate stages with a new form of interactive art that blends cryptocurrency, creativity, and community. Built around Bunz, Bitget's mascot, the installation positions a large mascot at its core. Bunz wraps the mirrored 360° sanctuary at the center of ₿itopia, inviting visitors into a space that is equal parts sculpture and experience. By day, it reflects the surrounding forest; by night, it becomes a living canvas, accompanied by interactive light and sound. Visitors enter Bunz's heart and trigger a biometric heartbeat sensor, sending pulses into a digital bloom of AI-generated flora that evolves in real time. The result is a shared tapestry of lived presence, shaped by imagination, biology, and blockchain.
